Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Metabolic Diseases Header 4
News: December 2022 News from our partners at Consultant360

Noninvasive Screening Tool Identifies Preschool Patients at Elevated Risk for Asthma
Researchers aimed to determine whether a symptom-based screening tool could accurately identify children who may be at a high risk of asthma to reduce the burden of disease in this patient population.

 Subsets of Eosinophils in Induced Sputum in Patients With Allergic Asthma Identified
Researchers aimed to investigate the possibility of differentiating between eosinophil subsets in the induced sputum of patients with allergic asthma and to ascertain the distribution of these subsets in different bronchial inflammatory phenotypes.

 Established Treatment For Severe Eosinophilic Asthma Shows Clinical Efficacy For Patients With Asthma, COPD
Treatment with interleukin-5/interleukin-5 receptor antibodies is clinically effective in patients with severe eosinophilic asthma and COPD.

 Biomarkers, Early Disease Pathogenesis of Lung Disease: Critical Observations in Pulmonary Medicine, Ep. 8
Albert Rizzo, MD, interviews MeiLan Han, MD, MS, about chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, asthma, and pulmonary fibrosis, including an overview of recent cohort studies investigating important biomarkers of COPD, early disease pathogenesis, the future of therapies, and identifying patients for spirometry. 

 Presentation and Pathogenesis of EoE
In this video, Jonathan A. Bernstein, MD, speaks about the pathogenesis of eosinophilic esophagitis and reviews the recent guidelines from The American Gastroenterology Association for the management of patients with eosinophilic esophagitis. Dr Bernstein also spoke about these topics during his session titled “Presentation and Pathogenesis of EoE” at ACAAI Annual Scientific Meeting 2022.